Description
Inmunoglobulina antitimocítica (ATG) 25 mg
Cáncer de mama HER2 positivo residual tras terapia neoadyuvante
Uso continuo bajo seguimiento endocrinológico
Prevención de eventos trombóticos según criterio médico
PRINCIPIO ACTIVO: MUPIROCINA 0
PANAL HUGG ULT-CONF NINO E5 C40 INVESTIGACION FARMACEUTICA Inmunoglobulina antitimocítica (ATG) 25 mg40 Piezas Bolsa
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
